Amicus Therapeutics Inc (FOLD)
9.565
+0.06
(+0.68%)
USD |
NASDAQ |
Nov 22, 11:07
Amicus Therapeutics Total Liabilities (Quarterly): 607.73M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 607.73M |
| June 30, 2024 | 616.96M |
| March 31, 2024 | 591.10M |
| December 31, 2023 | 617.71M |
| September 30, 2023 | 630.85M |
| June 30, 2023 | 618.51M |
| March 31, 2023 | 597.95M |
| December 31, 2022 | 601.12M |
| September 30, 2022 | 626.96M |
| June 30, 2022 | 627.16M |
| March 31, 2022 | 588.32M |
| December 31, 2021 | 597.77M |
| September 30, 2021 | 580.05M |
| June 30, 2021 | 572.98M |
| March 31, 2021 | 559.14M |
| December 31, 2020 | 600.14M |
| September 30, 2020 | 580.27M |
| June 30, 2020 | 340.50M |
| March 31, 2020 | 335.76M |
| December 31, 2019 | 373.78M |
| September 30, 2019 | 334.02M |
| June 30, 2019 | 317.98M |
| March 31, 2019 | 313.03M |
| December 31, 2018 | 447.04M |
| September 30, 2018 | 427.64M |
| Date | Value |
|---|---|
| June 30, 2018 | 263.99M |
| March 31, 2018 | 348.39M |
| December 31, 2017 | 274.17M |
| September 30, 2017 | 271.10M |
| June 30, 2017 | 672.07M |
| March 31, 2017 | 682.60M |
| December 31, 2016 | 676.69M |
| September 30, 2016 | 581.62M |
| June 30, 2016 | 579.76M |
| March 31, 2016 | 551.28M |
| December 31, 2015 | 560.55M |
| September 30, 2015 | 607.94M |
| June 30, 2015 | 75.01M |
| March 31, 2015 | 88.61M |
| December 31, 2014 | 87.79M |
| September 30, 2014 | 82.21M |
| June 30, 2014 | 81.69M |
| March 31, 2014 | 81.27M |
| December 31, 2013 | 81.81M |
| September 30, 2013 | 42.62M |
| June 30, 2013 | 42.78M |
| March 31, 2013 | 39.88M |
| December 31, 2012 | 40.87M |
| September 30, 2012 | 41.45M |
| June 30, 2012 | 38.43M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
335.76M
Minimum
Mar 2020
630.85M
Maximum
Sep 2023
563.24M
Average
597.86M
Median
Total Liabilities (Quarterly) Benchmarks
| Tonix Pharmaceuticals Holding Corp | 20.78M |
| Alnylam Pharmaceuticals Inc | 4.173B |
| Ionis Pharmaceuticals Inc | 2.419B |
| Arbutus Biopharma Corp | 33.55M |
| Krystal Biotech Inc | 96.47M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 786.56M |
| Shareholders Equity (Quarterly) | 178.82M |
| Debt to Equity Ratio | 2.178 |
| Current Ratio | 3.152 |
| Net Debt Paydown Yield | 0.02% |